AI
Friday, February 10, 2017 8:27:18 AM
IMMU - 4.30 Pre-market now at 4.74/4.75.
Immunomedics Shares Eye 3-Yr High Pre-Bell Licenses Tumor-Fighting Drug To Seattle Genetics For Up To $2 Bln
Immunomedics Shares Eye 3-Yr High Pre-Bell Licenses Tumor-Fighting Drug To Seattle Genetics For Up To $2 Bln
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
